Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2578 (LINC02578), also designated as RP11-127L21.1, encodes a long intergenic non-coding RNA (lincRNA) in humans[6]. LincRNAs are a subclass of long non-coding RNAs (lncRNAs), defined as transcripts longer than 200 nucleotides that do not overlap with protein-coding genes[3][7]. These RNAs are typically involved in the regulation of gene transcription and chromatin architecture, acting through mechanisms such as scaffolding chromatin-modifying complexes, modulating transcription factors, or altering the stability of target RNAs, often exhibiting tissue-specific expression[3][5]. The specific molecular and biological functions of LINC02578 have not yet been experimentally defined or reported in reviewed literature or databases[1][6]. There are no drugs, validated disease associations, or clinical uses currently attributed to LINC02578.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2578 (LINC02578).